Conference Videos

Paradise Renal Denervation System Shows Significant Blood Pressure Reduction in Hypertensive Patients. PCR, #euroPCR 2018
News | Renal Denervation | May 30, 2018

May 31, 2018 – ReCor Medical announced that the RADIANCE-HTN SOLO...

Orsiro DES Shows Lowest Two-Year Target Lesion Failure in BIO-RESORT Trial
News | Stents Drug Eluting | May 31, 2018

May 31, 2018 — Two-year outcome data from the BIO-RESORT randomized controlled trial were presented in a late-...

An example of an intra-aortic balloon pump (IABP) from Maquet. The results of the SEMPER FI trial. #europcr2018 #Europcr

An example of an intra-aortic balloon pump (IABP) from Maquet. 

Feature | Intra-Aortic Balloon Pumps (IABP) | May 31, 2018

May 31, 2018 — The results from the Survival Improvement in Extensive Myocardial Infarction with PERsistent Ischemia...

An example of renal denervation therapy being delivered. A catheter is inserted into the renal artery to ablate the nerves in the vessel wall that regulate vasoconstriction. This leaves the vessel permanently in the widest open position to allow greater blood flow to the kidneys.

An example of renal denervation therapy being delivered. A catheter is inserted into the renal artery to ablate the nerves in the vessel wall that regulate vasoconstriction. This leaves the vessel permanently in the widest open position to allow greater blood flow to the kidneys.

Feature | Renal Denervation | May 30, 2018

May 30, 2018 — Despite the best efforts of clinicians to manage hypertension, it continues to increase and is now...

Shockwave Launches Coronary Intravascular Lithotripsy in Europe
News | Cath Lab | May 30, 2018

May 30, 2018 — Shockwave Medical recently announced the European commercial availability of...

OCT Reveals Excellent Healing Profile for Complex CAD Patients With Resolute Onyx DES
News | Stents Drug Eluting | May 29, 2018

May 29, 2018 – Investigators recently unveiled...

FFR software on the GE Centricity CVIS. A trial from the 2018 EuroPCR meeting showed FFR improves long-term outcomes.
News | Cath Lab | May 29, 2018

May 29, 2018 — Ongoing controversy exists regarding the role of percutaneous coronary intervention (PCI) for stable...

The ORBITA Trial showed FFR and iFR are good predictors of PCI outcomes. This was a 2018 PCR late-breaker.
News | FFR Technologies | May 29, 2018

May 29, 2018 — The first placebo-controlled trial that looked at how fractional flow reserve (FFR) and instantaneous...

EuroPCR conference live case presentation. PCR late-breaking trials.
Feature | EuroPCR | May 31, 2018

Here are the late-breaking trials and other key study presentations from the 2018 EuroPCR conference. This is the...

First-in-human Electroporation Ablation Study Finds Pulsed Electric Fields Can Target Specific Tissue For Atrial Fibrillation. #HRS2018 #HRS18

Figure 1: Images showing the effect of both surgical epicardial PEF ablation and catheter based PEF ablation in the first-in-human electroporation ablation study to freat Afib.

News | May 25, 2018

May 25, 2018 — Data from the first-in-human study using pulsed electric field (PEF) energy ablate heart tissue in...

Tendyne Transcatheter Mitral Valve Replacement Device Demonstrates Positive 30-Day Outcomes
News | Heart Valve Technology | May 25, 2018

May 25, 2018 — Abbott announced favorable outcomes from the first 100 patients treated in a...

Abbott's Xience Sierra Stent Receives FDA Approval
Technology | Stents Drug Eluting | May 25, 2018

May 25, 2018 — Abbott announced it received approval from the U.S. Food and Drug Administration (FDA) for Xience...

Overlay Init